MYLERAN vs VIVIMUSTA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate

Possible drug interaction. MYLERAN and VIVIMUSTA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	MYLERAN	VIVIMUSTA
Rating	New	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	BUSULFAN	BENDAMUSTINE HYDROCHLORIDE
Manufacturer	Waylis Therap	Azurity
Dosage forms	Tablet	Injectable
Drug class	Alkylating Drug	Alkylating Drug
Boxed warning	Boxed warning	None
Treats	Polycythemia Vera, Bcr-Abl Positive Chronic Myelogenous Leukemia, Primary Myelofibrosis	Lymphoid Leukemia, Non-Hodgkin Lymphoma

myleran vivimusta

Rating

New

70/100

Pharmacy pays

—

Type

Active ingredient

BUSULFAN

BENDAMUSTINE HYDROCHLORIDE

Manufacturer

Waylis Therap

Azurity

Dosage forms

Tablet

Injectable

Drug class

Alkylating Drug

Boxed warning

None

Treats

Polycythemia Vera, Bcr-Abl Positive Chronic Myelogenous Leukemia, Primary Myelofibrosis

Lymphoid Leukemia, Non-Hodgkin Lymphoma

Frequently asked questions

What is the difference between Myleran and Vivimusta?

Myleran contains Busulfan, while Vivimusta contains Bendamustine Hydrochloride — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.